Biosimilars are an opportunity to help reduce the burden of rising treatment costs.
Diversity drives innovation, which in turn drives change and progress.
Sandoz announced a commitment of $10 million USD in medicines to Americares.
At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.
This site is intended for a US audience